Effects of intracerebroventricular and intravenous administration of Kisspeptin-54 and Gonadotropin-releasing hormone agonist in rats with ovarian hyperstimulation

Abbara, 2015, Efficacy of kisspeptin 54 to trigger oocyte maturation in women at high risk of OHSS during IVF therapy, J. Clin. Endocrinol. Metab., 100, 3322, 10.1210/jc.2015-2332 Aboulghar, 2003, Prediction of ovarian hyperstimulation syndrome (OHSS)- estradiol level has an important role in the prediction of OHSS, Hum. Reprod., 18, 10.1093/humrep/deg208 Agırman, 2021, Signaling inflammation across the gut-brain axis, Science, 26, 1087, 10.1126/science.abi6087 Atilgan, 2019, What is the impact of short- and long-term supplementation of either cabergoline or clarithromycin on resolving rat ovarian hyperstimulation syndrome (OHSS) model?, J. Obstet. Gynaecol., 39, 687, 10.1080/01443615.2018.1563774 Banks, 2005, Blood-brain barrier transport of cytokines: a mechanism for neuropathology, Curr. Pharm. Des., 11, 973, 10.2174/1381612053381684 Banks, 1991, Human interleukin (IL) 1α, murine IL-1α and murine IL-1β are transported from blood to brain in the mouse by a shared saturable mechanism, J. Pharmacol. Exp. Ther., 259, 988 Bates, 2002, Regulation of vascular permeability by vascular endothelial growth factors, Vasc. Pharmacol., 39, 225, 10.1016/S1537-1891(03)00011-9 Birinci, 2021, Effect of kisspeptin-54 on ovarian levels of pigment epithelium- derived factor (PEDF) and vascular endothelial growth factor (VEGF) in an experimental model of ovarian hyperstimulation syndrome (OHSS), Reprod. Fertil. Dev., 33, 799, 10.1071/RD21140 De Roux, 2003, Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54, Proc. Natl. Acad. Sci., 100, 10972, 10.1073/pnas.1834399100 Dhillo, 2005, Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis in human males, J. Clin. Endocrinol. Metabol., 90, 6609, 10.1210/jc.2005-1468 Farkas, 2020, Comparative analysis of abdominal fluid cytokine levels in ovarian hyperstimulation syndrome (OHSS), J. Ovarian Res., 13, 25, 10.1186/s13048-020-00624-9 Fu, 2018, Effects of acupuncture on the levels of serum estradiol and pituitary estrogen receptor beta in a rat model of induced super ovulation, Life Sci., 197, 109, 10.1016/j.lfs.2018.02.005 George, 2011, Kisspeptin-10 is a potent stimulator of LH and increases pulse frequency in men, J. Clin. Endocrinol. Metab., 96, 1228, 10.1210/jc.2011-0089 Gill, 2002, Evidence that GnRH decreases with gonadal steroid feedback but increases with age in postmenopausal women, J. Clin. Endocrinol. Metab., 87, 2290, 10.1210/jcem.87.5.8508 Golan, 1989, Ovarian hyperstimulation syndrome: an update review, Obstet. Gynecol. Surv., 44, 430, 10.1097/00006254-198906000-00004 Gomez, 2002, Vascular endothelial growth factor receptor-2 activation induces vascular permeability in hyperstimulated rats, and this effect is prevented by receptor blockade, Endocrinology., 143, 4339, 10.1210/en.2002-220204 Hortu, 2021, Oxytocin and cabergoline alleviate ovarian hyperstimulation syndrome (OHSS) by suppressing vascular endothelial growth factor (VEGF) in an experimental model, Arch. Gynecol. Obstet., 303, 1099, 10.1007/s00404-020-05855-1 Hu, 2018, Kisspeptin/kisspeptin receptor system in the ovary, Front. Endocrinol. (Lausanne)., 4, 365, 10.3389/fendo.2017.00365 Humaidan, 2011, GnRH agonist for triggering of final oocyte maturation: time for a change of practice, Hum. Reprod. Update, 17, 510, 10.1093/humupd/dmr008 Humaidan, 2016, Ovarian hyperstimulation syndrome:review and new classification criteria for reporting in clinical trials, Hum. Reprod., 31, 1997, 10.1093/humrep/dew149 Jafari, 2017, IHC optical density score: a new practical method for quantitative immunohistochemistry image analysis, Appl. Immunohistochem. Mol. Morphol., 25 Järvelä, 2014, Controlled ovarian hyperstimulation leads to high progesterone and estradiol levels during early pregnancy, Hum. Reprod., 29, 1, 10.1093/humrep/deu223 Jayasena, 2013, A single injection of kisspeptin-54 temporarily increases luteinizing hormone pulsatility in healthy women, Clin. Endocrinol., 79, 558, 10.1111/cen.12179 Jayasena, 2014, Kisspeptin-54 triggers egg maturation in women undergoing in vitro fertilization, J. Clin. Invest., 124, 3667, 10.1172/JCI75730 Kasum, 2016, Combined ovulation triggering with GnRH agonist and hCG in IVF patients, Gynecol. Endocrinol., 32, 861, 10.1080/09513590.2016.1193141 Khlevner, 2018, Brain–gut axis clinical implications, Gastroenterol. Clin. N. Am., 47, 727, 10.1016/j.gtc.2018.07.002 Kitajima, 2004, Gonadotropin-releasing hormone agonist administration reduced vascular endothelial growth factor (VEGF), VEGF receptors, and vascular permeability of the ovaries of hyperstimulated rats, Fertil. Steril., 81, 842, 10.1016/j.fertnstert.2003.11.012 Kosmas, 2015, Everolimus, an mTOR pathway inhibitor, is highly successful on ovarian hyperstimulation syndrome by reducing ovarian weight and progesterone levels: a preclinical experimental randomized controlled study, Gynecol. Endocrinol., 31, 702, 10.3109/09513590.2015.1065479 Kotani, 2001, The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54, J. Biol. Chem., 276, 34631, 10.1074/jbc.M104847200 Mathur, 1997, The possible role of the immune system in the aetiopathogenesis of ovarian hyperstimulation syndrome, Hum. Reprod., 12, 2629, 10.1093/humrep/12.12.2629 Merhi, 2016, Ovarian kisspeptin expression is related to age and to monocyte chemoattractant protein-1, J. Assist. Reprod. Genet., 33, 535, 10.1007/s10815-016-0672-x Nastri, 2010, Ovarian hyperstimulation syndrome: pathophysiology and prevention, J. Assist. Reprod. Genet., 27, 121, 10.1007/s10815-010-9387-6 Nikitina, 2020, Plasma kisspeptin levels in boys with hypogonadotropic delayed puberty, Min. Endocrinol. June, 45, 79 Ohba, 2003, Ovarian hyperstimulation syndrome-model rats; the manifestation and clinical implication, Mol. Cell. Endocrinol., 202, 47, 10.1016/S0303-7207(03)00061-3 Osburg, 2002, Effect of endotoxin on expression of TNF receptors and transport of TNF-alpha at the blood-brain barrier of the rat, Am. J. Phys., 283, E899 Owens, 2018, The direct and indirect effects of kisspeptin-54 on granulosa lutein cell function, Hum. Reprod., 1, 292, 10.1093/humrep/dex357 Paxinos, 2007 Pheng, 2009, Potencies of centrally- or peripherally-injected full-length Kisspeptin or its C-terminal decapeptide on LH release in intact male, J. Reprod. Dev., 55, 378, 10.1262/jrd.20240 Podfigurna, 2020, Kisspeptin and LH pulsatility in patients with functional hypothalamic amenorrhea, Endocrine, 70, 635, 10.1007/s12020-020-02481-4 Ren, 2022, Pregnancy outcomes in patients with late-onset severe OHSS following different methods of ascetic fluid drainage and a comparison with non-OHSS IVF patients, Arch. Gynecol. Obstet., 305, 1587, 10.1007/s00404-021-06326-x Scotti, 2011, Administration of a gonadotropin-releasing hormone agonist affects corpus luteum vascular stability and development and induces luteal apoptosis in a rat model of ovarian hyperstimulation syndrome, Mol. Cell. Endocrinol., 335, 116, 10.1016/j.mce.2011.01.002 Singh, 2021, MCP-1: function, regulation, and involvement in disease, Int. Immunopharmacol., 101, 10.1016/j.intimp.2021.107598 Ujioka, 1997, Role of progesterone in capillary permeability in hyperstimulated rats, Hum. Reprod., 12, 1629, 10.1093/humrep/12.8.1629 Varghese, 2014, IHC profiler: an open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples, PLoS One, 9, 10.1371/journal.pone.0096801 Zhai, 2017, Kisspeptin-10 inhibits OHSS by suppressing VEGF secretion, Reproduction., 154, 355, 10.1530/REP-17-0268